Nadela, Anna Liza D.
HRN: 26 05 79 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2024
CEFUROXIME 750MG (VIAL)
10/19/2024
10/26/2024
IV
400mg
Q8H
PCAP C
Waiting Final Action